BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36095092)

  • 61. Smokeless tobacco and cancer in women: implications for cancer research.
    Winn DM; Pickle LW
    Women Health; 1986; 11(3-4):253-66. PubMed ID: 3564503
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Heterogeneity of Harmful Constituent Profiles in Smokeless Tobacco Products from Five African Countries.
    Gomez F; Ayo-Yusuf O; Yershova K; Jain V; Alcheva A; Hatsukami DK; Parascandola M; Stepanov I
    Chem Res Toxicol; 2023 Dec; 36(12):1901-1911. PubMed ID: 38051542
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Invasive oral squamous cell carcinoma induced by concurrent smokeless tobacco and creamy snuff use: A case report.
    Panta P; Dhopathi SR; Gilligan G; Seshadri M
    Oral Oncol; 2021 Jul; 118():105354. PubMed ID: 34023217
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The relationship of shammah (Arabian snuff) chewing to the risk of oral cancer and oral potentially malignant disorders.
    Patil S; Alamir AWH; Arakeri G; Awan KH; Bhandi SH; Aljabab A; Maddur N; Gomez RS; Brennan PA
    J Oral Pathol Med; 2019 Jul; 48(6):425-432. PubMed ID: 30883922
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Examining Market Trends in Smokeless Tobacco Sales in the United States: 2011-2019.
    Delnevo CD; Hrywna M; Miller Lo EJ; Wackowski OA
    Nicotine Tob Res; 2021 Aug; 23(8):1420-1424. PubMed ID: 33241271
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Smokeless tobacco: association with increased cancer risk.
    Mattson ME; Winn DM
    NCI Monogr; 1989; (8):13-6. PubMed ID: 2654650
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risk for oral cancer associated to smoking, smokeless and oral dip products.
    Madani AH; Dikshit M; Bhaduri D
    Indian J Public Health; 2012; 56(1):57-60. PubMed ID: 22684175
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Microorganisms: crucial players of smokeless tobacco for several health attributes.
    Vishwakarma A; Verma D
    Appl Microbiol Biotechnol; 2021 Aug; 105(16-17):6123-6132. PubMed ID: 34331556
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Smokeless tobacco and cancer.
    Boffetta P; Hecht S; Gray N; Gupta P; Straif K
    Lancet Oncol; 2008 Jul; 9(7):667-75. PubMed ID: 18598931
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessing the Risk of Oral Cancer associated with Gutka and Other Smokeless Tobacco Products: A Case-control Study.
    Awan KH; Hussain QA; Patil S; Maralingannavar M
    J Contemp Dent Pract; 2016 Sep; 17(9):740-744. PubMed ID: 27733717
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Smokeless tobacco use and cancer of the upper respiratory tract.
    Rodu B; Cole P
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 May; 93(5):511-5. PubMed ID: 12075196
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evidence supporting product standards for carcinogens in smokeless tobacco products.
    Hatsukami DK; Stepanov I; Severson H; Jensen JA; Lindgren BR; Horn K; Khariwala SS; Martin J; Carmella SG; Murphy SE; Hecht SS
    Cancer Prev Res (Phila); 2015 Jan; 8(1):20-6. PubMed ID: 25524878
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
    Richter P; Hodge K; Stanfill S; Zhang L; Watson C
    Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The need for regulation of carcinogenic N-nitrosamines in oral snuff.
    Djordjevic MV; Brunnemann KD; Hoffmann D
    Food Chem Toxicol; 1993 Jul; 31(7):497-501. PubMed ID: 8340028
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines.
    Stanfill SB; Connolly GN; Zhang L; Jia LT; Henningfield JE; Richter P; Lawler TS; Ayo-Yusuf OA; Ashley DL; Watson CH
    Tob Control; 2011 May; 20(3):e2. PubMed ID: 21109685
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chromium Exposure in the Adult Population, Consuming Different Types of Smokeless Tobacco Products in Pakistan.
    Akhtar A; Afridi HI; Kazi TG; Talpur FN; Arain SS; Baig JA; Khan N; Khan M; Bilal M
    Biol Trace Elem Res; 2017 Feb; 175(2):312-321. PubMed ID: 27422637
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chemistry and toxicology of smokeless tobacco.
    Bhisey RA
    Indian J Cancer; 2012; 49(4):364-72. PubMed ID: 23442400
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Snus and Snuff Use in Switzerland Among Young Men: Are There Beneficial Effects on Smoking?
    Gmel G; Clair C; Rougemont-Bücking A; Grazioli VS; Daeppen JB; Mohler-Kuo M; Studer J
    Nicotine Tob Res; 2018 Sep; 20(11):1301-1309. PubMed ID: 29059425
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epidemiologic Pattern and Types of Oral Smokeless Tobacco Usage in Saudi Arabia.
    Alrashidi AG; Alrashidi TG; Alrashedi SA; Alreshidi NA; Alrashidi MF; Alrashidi AS; Alkhaldi EH; Alrashdi AG; Alshammari MS; Ahmed HG
    J Contemp Dent Pract; 2018 Apr; 19(4):456-462. PubMed ID: 29728553
    [No Abstract]   [Full Text] [Related]  

  • 80. No association between moist oral snuff (snus) use and oral cancer: pooled analysis of nine prospective observational studies.
    Araghi M; Galanti MR; Lundberg M; Liu Z; Ye W; Lager A; Engström G; Alfredsson L; Knutsson A; Norberg M; Wennberg P; Lagerros YT; Bellocco R; Pedersen NL; Östergren PO; Magnusson C
    Scand J Public Health; 2021 Dec; 49(8):833-840. PubMed ID: 32466721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.